Journal of Korean Traditional Oncology (대한암한의학회지)
- Volume 16 Issue 1
- /
- Pages.55-61
- /
- 2011
- /
- 1975-244X(pISSN)
- /
- 2765-4850(eISSN)
DOI QR Code
A Case of Non-small Cell Lung Cancer Patient Whose Dermatologic Adverse Reactions Associated with the Epidermal Growth Factor Receptor-inhibitors were Relieved with the Treatment of a Herbal medicine, Samultang-gagambang
비소세포폐암 환자의 표피성장인자 수용체 억제제 치료와 관련된 피부의 이상반응이 사물탕 가감방 투여로 호전된 1례
- Park, Hyeong-Jun (Clinical Oncology of Korean Medicine, Dept. of Clinical Oriental Medicine, Kyung Hee University) ;
- Chae, Jean (Clinical Oncology of Korean Medicine, Dept. of Clinical Oriental Medicine, Kyung Hee University) ;
- Lee, Jin-Soo (Clinical Oncology of Korean Medicine, Dept. of Clinical Oriental Medicine, Kyung Hee University) ;
- Jung, Hyun-Sik (Dept. of Oriental Internal Medicine, Kyung Hee University Hospital at Gangdong) ;
- Lee, Sang-Hun (Dept. of Oriental Internal Medicine, Kyung Hee University Hospital at Gangdong) ;
-
Choi, Won-Cheol
(Clinical Oncology of Korean Medicine, Dept. of Clinical Oriental Medicine, Kyung Hee University) ;
- Kim, Kyung-Suk (Dept. of Oriental Internal Medicine, Kyung Hee University Hospital at Gangdong)
- 박형준 (경희대학교 임상한의학과 한방임상종양학) ;
- 채진 (경희대학교 임상한의학과 한방임상종양학) ;
- 이진수 (경희대학교 임상한의학과 한방임상종양학) ;
- 정현식 (강동경희대학교병원 한방내과) ;
- 이상헌 (강동경희대학교병원 한방내과) ;
-
최원철
(경희대학교 임상한의학과 한방임상종양학) ;
- 김경석 (강동경희대학교병원 한방내과)
- Received : 2011.06.13
- Accepted : 2011.06.20
- Published : 2011.06.28
Abstract
Objectives : Epidermal growth factor receptor-inhibitors have demonstrated improved overall survival in patients with non-small cell lung cancer, but their use is associated with dermatologic adverse reactions that often require symptomatic treatment. Methods : A 44-year-old woman, who started the chemotherapy of Iressa